These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11967802)

  • 1. AT(1)-signalling in vascular smooth muscle.
    Hughes AD
    J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):125-30. PubMed ID: 11967802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Signal transduction mechanisms mediating the physiological and pathophysiological actions of angiotensin II in vascular smooth muscle cells.
    Touyz RM; Schiffrin EL
    Pharmacol Rev; 2000 Dec; 52(4):639-72. PubMed ID: 11121512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin II signal transduction through the AT1 receptor: novel insights into mechanisms and pathophysiology.
    Higuchi S; Ohtsu H; Suzuki H; Shirai H; Frank GD; Eguchi S
    Clin Sci (Lond); 2007 Apr; 112(8):417-28. PubMed ID: 17346243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular and cell biology of angiotensin receptors.
    Hanley MR
    J Cardiovasc Pharmacol; 1991; 18 Suppl 2():S7-13. PubMed ID: 1725048
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin receptors in the cardiovascular system.
    Wagenaar LJ; Voors AA; Buikema H; van Gilst WH
    Can J Cardiol; 2002 Dec; 18(12):1331-9. PubMed ID: 12518185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine decreases angiotensin II receptor binding in vascular smooth muscle cells.
    Ullian ME; Gelasco AK; Fitzgibbon WR; Beck CN; Morinelli TA
    J Am Soc Nephrol; 2005 Aug; 16(8):2346-53. PubMed ID: 15944340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression and function of vascular alpha1D-adrenoceptors may mediate the prohypertensive effects of angiotensin II.
    Villalobos-Molina R; Ibarra M
    Mol Interv; 2005 Dec; 5(6):340-2. PubMed ID: 16394249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signal transduction in vascular smooth muscle.
    Alexander RW; Griendling KK
    J Hypertens Suppl; 1996 Dec; 14(5):S51-4. PubMed ID: 9120685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in intracellular signalling in hypertension.
    Touyz RM
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):165-74. PubMed ID: 12589177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
    Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
    Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin IV activates the nuclear transcription factor-kappaB and related proinflammatory genes in vascular smooth muscle cells.
    Esteban V; Ruperez M; Sánchez-López E; Rodríguez-Vita J; Lorenzo O; Demaegdt H; Vanderheyden P; Egido J; Ruiz-Ortega M
    Circ Res; 2005 May; 96(9):965-73. PubMed ID: 15831814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How to explain the differences between renin angiotensin system modulators.
    Levy BI
    Am J Hypertens; 2005 Sep; 18(9 Pt 2):134S-141S. PubMed ID: 16125050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of signal transduction during vascular smooth muscle cell proliferation induced by autoantibodies against angiotensin AT1 receptor from hypertension.
    Sun YX; Zhang HY; Wei YM; Zhu F; Wang M; Liao YH
    Chin Med J (Engl); 2008 Jan; 121(1):43-8. PubMed ID: 18208665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in angiotensin II type 1 receptor signalling pathways evoked by a monoclonal antibody raised to the N-terminus.
    Xiao F; Puddefoot JR; Barker S; Vinson GP
    J Endocrinol; 2008 Apr; 197(1):25-33. PubMed ID: 18372229
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy].
    Castro-Chaves P; Leite-Moreira AF
    Rev Port Cardiol; 2004 May; 23 Suppl 2():II61-77. PubMed ID: 15222251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear accumulation of the AT1 receptor in a rat vascular smooth muscle cell line: effects upon signal transduction and cellular proliferation.
    Cook JL; Mills SJ; Naquin R; Alam J; Re RN
    J Mol Cell Cardiol; 2006 May; 40(5):696-707. PubMed ID: 16516913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
    Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin II as a pro-inflammatory mediator.
    Phillips MI; Kagiyama S
    Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.